Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Alphabet Inc.
  6. News
  7. Summary
    GOOGL   US02079K3059

ALPHABET INC.

(GOOGL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Google Strikes Deal With Hospital Chain to Develop Healthcare Algorithms -- 2nd Update

05/26/2021 | 02:49pm EDT

By Melanie Evans

Alphabet Inc.'s Google and national hospital chain HCA Healthcare Inc. have struck a deal to develop healthcare algorithms using patient records, the latest foray by a tech giant into the $3 trillion healthcare sector.

HCA, which operates across about 2,000 locations in 21 states, would consolidate and store with Google data from digital health records and internet-connected medical devices under the multiyear agreement. Google and HCA engineers will work to develop algorithms to help improve operating efficiency, monitor patients and guide doctors' decisions, according to the companies.

"Data are spun off of every patient in real time," said Dr. Jonathan Perlin, chief medical officer of HCA, which is based in Nashville, Tenn. "Part of what we're building is a central nervous system to help interpret the various signals."

The deal expands Google's reach in healthcare, where the recent shift to digital records has created an explosion of data and a new market for technology giants and startups. Data crunching offers the opportunity to develop new treatments and improve patient safety, but algorithm-development deals between hospitals and tech companies have also raised privacy alarms.

Google has previously reached deals with other prominent U.S. hospital systems, including St. Louis-based Ascension, that granted access to personal patient information, drawing public scrutiny.

Google and Ascension sought to develop a search tool for patient information. The work, dubbed "Project Nightingale" and described in articles by The Wall Street Journal, prompted an outcry over privacy of patient records shared with Google, which included names, dates of birth and medication information. The companies said the effort complied with federal privacy laws.

Google also reached an ambitious deal with Mayo Clinic that combined storage of voluminous medical, genetic and financial data with algorithm-development efforts. The Google deal with Mayo allows Google access to identifying patient information, when needed.

Other tech giants have struck similar deals with hospitals that grant access to identifying information in technology development, such as an effort by Microsoft Corp. and hospital system Providence to use patient records to develop cancer algorithms.

HCA said Google isn't permitted to use patient-identifiable information under the agreement. Dr. Perlin said HCA patient records would be stripped of identifying information before being shared with Google data scientists and that the hospital system would control access to the data. Terms of the deal weren't disclosed by the companies.

Google will access data when needed with consent from HCA, but the tech giant can develop analytic tools without patient records and allow HCA to test the models independently, said Chris Sakalosky, managing director of healthcare and life sciences at Google Cloud. "We want to push the boundaries of what the clinician can do in real time with data, " he said.

Personal patient information is protected under the federal health-privacy law, known as the Health Insurance Portability and Accountability Act. The law allows hospitals and some other healthcare companies, such as health insurers, to share information with contractors, which must also abide by the law's privacy protections.

Some consider the federal law outdated, saying the law's protections haven't kept pace with the technology sector's growing demand for patient data, said Michelle Mello, a Stanford University professor of law and medicine who focuses on health-data privacy.

Companies may also use the data under the law in ways to develop products that boost corporate profit, with no visibility or control for patients over how their data is used. "Some people just don't want their data used in particular ways by particular parties," said Dr. Mello, who has served as an adviser to Alphabet's Verily Life Sciences.

Health and technology giants have pushed into healthcare data aggregation and algorithm development with mixed results. International Business Machines Corp. has explored a sale of its IBM Watson Health business, as the company's healthcare artificial-intelligence unit struggled, The Wall Street Journal reported in February.

Hospitals are uniquely positioned as brokers for data created by patients seeking care and interacting with doctors, laboratories, pharmacies and medical devices. They have increasingly sought to capitalize on that data in deals to aggregate patient records or develop products with pharmaceutical and technology companies. "They aren't sleeping on this opportunity either," said Jeffrey Becker, principal analyst for healthcare at CB Insights.

Fourteen hospital systems in February announced a newly formed company, Truveta Inc., to sell access to their anonymized records for patients across 40 states. Other hospitals have invested in health-record analytic companies, such as Health Catalyst Inc., which went public in 2019.

The multiyear HCA-Google agreement will seek to develop algorithms using data from 32 million annual patient visits that could help monitor patients and guide treatment, said Dr. Perlin. During the pandemic, HCA used its own technology to monitor critically ill Covid-19 patients and notify doctors of potentially better treatment options. The company found that survival rates increased by comparing the outcomes for patients before and after rolling out the algorithm.

The companies will also seek to develop algorithms that would help improve operations, Dr. Perlin said, such as by automating how hospital units track inventory of critical supplies.

Write to Melanie Evans at Melanie.Evans@wsj.com

(END) Dow Jones Newswires

05-26-21 1649ET

Stocks mentioned in the article
ChangeLast1st jan.
ALPHABET INC. -0.20% 2708.25 Delayed Quote.53.89%
DJ INDUSTRIAL -0.85% 34828.86 Delayed Quote.13.83%
HCA HEALTHCARE, INC. -1.19% 250.56 Delayed Quote.54.15%
HEALTH CATALYST, INC. -0.62% 57.055 Delayed Quote.31.89%
INTERNATIONAL BUSINESS MACHINES CORPORATION -0.84% 142.94 Delayed Quote.14.45%
MICROSOFT CORPORATION -0.33% 286.355 Delayed Quote.29.09%
S&P 500 -0.42% 4406.04 Delayed Quote.16.80%
All news about ALPHABET INC.
03:01aEPAZZ HOLDINGS : ZenaPay Bitcoin Wallet Will Support Linking to Credit and Debit..
DJ
08/03PRESS RELEASE : Expanding Online Media Market, Merxwire Integrates Online Video ..
DJ
08/03McDonald's makes masks mandatory for some U.S. customers, staff (Aug. 2)
RE
08/03SCHNEIDER ELECTRIC : Partners With Livspace To Offer Services In India
MT
08/03Global markets live: Sanofi, Alphabet, BMW, Ford, Tencent...
08/03DOW JONES FXCM DOLLAR INDEX : Nomura Says Proprietary Data Shows India's Busines..
MT
08/02Google to launch own processor for upcoming Pixel phones
RE
08/02Financial regulators urgently need to get a grip on 'Big Tech' -BIS
RE
08/02STREET COLOR : Qualcomm Spokesperson Says Company Will Continue to Work With Goo..
MT
08/02Google to launch own processor for upcoming Pixel phones
RE
More news
Financials (USD)
Sales 2021 250 B - -
Net income 2021 69 022 M - -
Net cash 2021 143 B - -
P/E ratio 2021 26,8x
Yield 2021 -
Capitalization 1 813 B 1 813 B -
EV / Sales 2021 6,67x
EV / Sales 2022 5,67x
Nbr of Employees 144 056
Free-Float 93,1%
Chart ALPHABET INC.
Duration : Period :
Alphabet Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALPHABET INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 47
Last Close Price 2 712,60 $
Average target price 3 141,16 $
Spread / Average Target 15,8%
EPS Revisions
Managers and Directors
Sundar Pichai Chief Executive Officer & Director
Ruth M. Porat Chief Financial Officer & Senior Vice President
John LeRoy Hennessy Chairman
Louis John Doerr Independent Director
Ann Mather Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ALPHABET INC.53.89%1 812 802
BAIDU, INC.-24.12%58 023
NAVER CORPORATION46.32%55 178
Z HOLDINGS CORPORATION-9.40%39 392
YANDEX N.V.-2.96%24 130
SOGOU INC.8.34%3 425